The conversation is about hair loss treatment using topical minoxidil, finasteride, and arginine, showing noticeable progress in one month. The user suggests adding arginine serum for better results.
The conversation discusses the delay in the PP405 Phase 2 study results, now expected by the end of 2025, and skepticism about research practices. There is also mention of optimism for Amplifica's AMP303 and a topical treatment in early testing.
Pelage is recruiting for phase 2 trials, showing promise for treating bald regions. The discussion highlights its potential effectiveness based on its mechanism of action.
PP405, developed by Pelage Pharmaceuticals, can reactivate dormant hair follicle stem cells and increase hair growth by 20% in eight weeks, unlike minoxidil or finasteride. However, skepticism remains about its effectiveness and availability, with concerns about funding and the timeline for broader access.
The user experienced significant hair regrowth using dutasteride, oral minoxidil, and ketoconazole shampoo, with no side effects except denser facial hair. They increased their dosages to 1mg dutasteride and 5mg oral minoxidil for better results.
VDPHL01 shows faster and stronger hair growth compared to standard minoxidil, with no major side effects reported. Users discuss combining it with other treatments like dutasteride and finasteride for better results, while expressing skepticism about the effectiveness of PP405.
A user shared their positive experience with Roots by GA, a company that creates personalized hair loss treatments based on DNA analysis, which confirmed their inability to tolerate finasteride. The user is satisfied with their progress 30 days after a hair transplant and the customized formula they received.
The conversation discusses hair loss treatments, specifically using Dutasteride, needling, and Minoxidil for temple regrowth. It highlights the importance of patience and managing expectations while trusting the process.
User experienced significant hair regrowth using minoxidil and dutasteride, along with microneedling, vitamins, and massages. Despite recent shedding, they hope it's a synchronized hair cycle and plan to continue the treatment.
PP405 is a promising molecule that may reactivate dormant hair follicles, potentially offering a new treatment for hair loss. It is in phase 2 trials, with possible availability between 2027 and 2030.
A user is experiencing hair regrowth after 2.5 months using dutasteride and a daily spray containing finasteride, minoxidil, biotin, and ketoconazole. They are optimistic about continued progress and have noticed new dark hairs forming.
People are discussing various hair loss treatments, including finasteride, minoxidil, RU58841, and new potential treatments like vdphl01, ABS-201, and KX-826. Some express hope in future developments like hair cloning and CRISPR, while others emphasize acceptance and sticking with current treatments.
The user started a hair loss treatment two months ago using oral minoxidil, dutasteride, finasteride, and biotin. They experience some side effects like ED but are willing to continue for hair growth.
The user is experiencing noticeable hair regrowth after 2 months using oral finasteride, topical minoxidil, weekly dermastamping, and ketoconazole shampoo. They report thicker hair, especially at the temples, and are surprised by the improvement.
Hair cloning and new treatments like ET-02, Veradermics (vdphl01), and wound-induced hair neogenesis show promise but are not yet widely available. Current effective treatments include minoxidil, finasteride, and dutasteride, with early intervention being crucial for better outcomes.
The user improved their hairline using topical minoxidil and oral finasteride, considering derma stamping for further temple regrowth. They believe finasteride thickened existing hairs while minoxidil promoted new hair growth.
The conversation discusses a new hair growth product called Arata MitoActive, which the original poster is considering as an alternative to minoxidil and finasteride, both of which were ineffective for them. Most responses suggest skepticism about the product's effectiveness, labeling it as potentially ineffective or a marketing gimmick.
PP405 is seen as a potential breakthrough for converting vellus hairs to terminal hairs, with users expressing both hope and skepticism. It is compared to treatments like minoxidil and finasteride, with discussions on side effects and marketing concerns.
A user is creating a custom topical hair regrowth serum using minoxidil, bimatoprost, tretinoin, castor oil, and hyaluronic acid. They are also using dutasteride, oral minoxidil, and castor oil in their current regimen.
The conversation is about using Maxogen-X, a topical solution containing minoxidil, finasteride, tretinoin, and azelaic acid, for hair loss treatment. Users discuss their experiences, including initial shedding and the hope for thicker hair, while sharing progress updates.
A user shared their 1-year hair regrowth progress using 1mg oral Finasteride, 5mg oral Minoxidil, 6% Minoxidil spray, Ketoconazole shampoo, and Hawthorne thickening shampoo and conditioner. They experienced thicker body hair as a side effect but no other issues.
The user is happy with their hair regrowth after two years of using finasteride, minoxidil, and biotin, reporting no side effects. They noticed significant improvement after one year and maintained consistent treatment to avoid shedding.
PP405 is moving to late-stage trials, showing potential for hair regrowth, with 31% of male patients experiencing a 20% increase in hair density. Veradermics is developing an oral minoxidil version, and there is interest in combining treatments for better results.
The user is considering changing their hair loss treatment from topical minoxidil and oral finasteride to oral minoxidil and oral dutasteride, with suggestions to add microneedling and possibly red light therapy. They are also exploring the addition of a caffeine and adenosine mix to their regimen.
Swanson Full Effect Hair Thickener is discussed for its potential to stop hair fall and aid regrowth. A user reported positive results but noted it's out of stock.
A 42-year-old user shared a 4-month update on their hair regrowth using a "nuclear stack" including oral and topical minoxidil, dutasteride, RU58841, micro-needling, keto shampoo, saw palmetto, biotin, multivitamins, scalp massages, and inversion table. They reported significant progress with minimal side effects and plan to continue the routine.
2% fucoidan alleviated AGA symptoms, promoted hair growth, and increased hair density in mice. Fucoidan is considered safe for humans as a supplement and topical skincare product, with potential therapeutic effects against AGA.
A 23-year-old male started using Redensyl and Aminexil, along with Tab BTN Ultra and Vitamin D3 supplements, for hair loss. He shared progress pictures after 45-50 days of treatment.
A user shared their hair regrowth progress using oral Dutasteride, Biotin, and Minoxidil over nine months, reporting significant improvement without surgery. They emphasized the effectiveness of these medications and noted no side effects.
The user reported significant hair regrowth over four months using oral minoxidil, dutasteride, and biotin. They take 0.5mg dutasteride, 2.5mg minoxidil, and 10mg biotin daily, with occasional extra biotin.